Literature DB >> 21340921

In vitro matrigel angiogenesis assays.

M L Ponce1.   

Abstract

A variety of in vivo and in vitro methods have been used to study angiogenesis, the process of blood vessel formation. Two widely accepted but technically difficult assays include the cornea implant assay and the chick chorioallantoic membrane assay. The cornea assay requires special equipment and a skilled person to implant beads containing the test compound in the eyes of animals; only a small number of samples can be tested due to cost and time. The chorioallantoic membrane assay requires a large number of samples on account of the variability of the system and its difficulty in quantitation. In our laboratory, we have developed a quick and highly reliable method for testing numerous compounds for angiogenic and/or antiangiogenic activity. The method is based on the differentiation of ECs on a basement membrane matrix, Matrigel, derived from the Engelbreth-Holm-Swarm tumor (1). ECs from human umbilical cords as well as from other sources differentiate and form capillary-like structures on Matrigel in the presence of 10% bovine calf serum (BCS) and 0.1 mg/mL of endothelial cell growth supplement (ECGS) (2), which is a mixture of both acidic and basic fibroblast growth factor (Fig. 1, Panel C). The formation of tube-like vessels under these conditions can be used to assess compounds that either inhibit or stimulate angiogenesis.

Entities:  

Year:  2001        PMID: 21340921     DOI: 10.1385/1-59259-143-4:205

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  12 in total

1.  Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E).

Authors:  Amjad Husain; Nina Hu; Peter M Sadow; Carmelo Nucera
Journal:  Cancer Lett       Date:  2015-07-17       Impact factor: 8.679

2.  Synthetic alternatives to Matrigel.

Authors:  Elizabeth A Aisenbrey; William L Murphy
Journal:  Nat Rev Mater       Date:  2020-05-27       Impact factor: 66.308

3.  Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells.

Authors:  Su-Li Cheng; Jian-Su Shao; Abraham Behrmann; Karen Krchma; Dwight A Towler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-16       Impact factor: 8.311

4.  Human proangiogenic circulating hematopoietic stem and progenitor cells promote tumor growth in an orthotopic melanoma xenograft model.

Authors:  Julie A Mund; Harlan Shannon; Anthony L Sinn; Shanbao Cai; Haiyan Wang; Kamnesh R Pradhan; Karen E Pollok; Jamie Case
Journal:  Angiogenesis       Date:  2013-07-23       Impact factor: 9.596

5.  Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites.

Authors:  Ronen Ben-Ami; Russell E Lewis; Konstantinos Leventakos; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113

6.  SCF(β-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2.

Authors:  Shavali Shaik; Carmelo Nucera; Hiroyuki Inuzuka; Daming Gao; Maija Garnaas; Gregory Frechette; Lauren Harris; Lixin Wan; Hidefumi Fukushima; Amjad Husain; Vania Nose; Guido Fadda; Peter M Sadow; Wolfram Goessling; Trista North; Jack Lawler; Wenyi Wei
Journal:  J Exp Med       Date:  2012-06-18       Impact factor: 14.307

7.  Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study.

Authors:  A Mukherjee; A D Westwell; T D Bradshaw; M F G Stevens; J Carmichael; S G Martin
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

8.  Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth.

Authors:  Halesha D Basavarajappa; Bit Lee; Xiang Fei; Daesung Lim; Breedge Callaghan; Julie A Mund; Jamie Case; Gangaraju Rajashekhar; Seung-Yong Seo; Timothy W Corson
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

9.  ERK1/2 and HIF1α Are Involved in Antiangiogenic Effect of Polyphenols-Enriched Fraction from Chilean Propolis.

Authors:  Alejandro Cuevas; Nicolás Saavedra; Martina Rudnicki; Dulcineia S P Abdalla; Luis A Salazar
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-10       Impact factor: 2.629

10.  Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.

Authors:  Mark Duquette; Peter M Sadow; Amjad Husain; Jennifer N Sims; Zeus A Antonello; Andrew H Fischer; Chen Song; Elena Castellanos-Rizaldos; G Mike Makrigiorgos; Junichi Kurebayashi; Vania Nose; Paul Van Hummelen; Roderick T Bronson; Michelle Vinco; Thomas J Giordano; Dora Dias-Santagata; Pier Paolo Pandolfi; Carmelo Nucera
Journal:  Oncotarget       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.